2 min read
Press Releases
2 min read
Novavax Selects AGC Biologics to Manufacture Matrix-M™ Adjuvant for Novel COVID-19 Vaccine
1 min read
AGC Biologics Acquires Commercial Facility, Expanding Global Service Offerings
2 min read
Takara Bio Selects AGC Biologics as Manufacturer of Plasmid DNA Intermediate for a Vaccine Against COVID-19 (SARS-CoV-2)
2 min read
AGC Biologics to Participate in First-Ever BIO Digital Conference
2 min read
AGC Biologics Partners with Faron Pharmaceuticals to Manufacture Cancer Treatment
AGC Biologics Manufactures Key Ingredient in Potential COVID-19 Treatment Drug, Leronlimab
2 min read
AdaptVac Partners with AGC Biologics to Develop & Produce COVID-19 Vaccine
2 min read